IVA vs JAGX

Inventiva S.A. - American Depos vs Jaguar Health, Inc. — Valuation Comparison 2026

IVA

Pharmaceutical Preparations
Inventiva S.A. - American Depos
Quality
4.4
out of 10
Value Trap
6
SAFE
Price
$4.93
Last close
Models
7/13
Active
VS

JAGX

Pharmaceutical Preparations
Jaguar Health, Inc.
Quality
4.2
out of 10
Value Trap
47
WARN
Price
$3.55
Last close
Models
4/13
Active

Model-by-Model Comparison

ModelType IVA Fair ValueIVA Upside JAGX Fair ValueJAGX Upside
Bayesian DCF Intrinsic $0.58 -88.3% — —
First Chicago Scenario $0.13 -97.4% $4.44 +27.9%
ML-RIV Intrinsic $0.50 -90.2% $0.66 -90.2%
PWERM Option-Based $5.84 +18.4% — —
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for IVA vs JAGX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IVA vs JAGX — Which Stock Is More Undervalued?

IVA scores higher with a 4.4/10 quality rating vs JAGX's 4.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Inventiva S.A. - American Depos (IVA) and Jaguar Health, Inc. (JAGX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IVA currently trades at $4.93 with a QOC of 4.4/10, while JAGX trades at $3.55 with a QOC of 4.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).

IVA
View Full Inventiva S.A. - American Depos Analysis →
JAGX
View Full Jaguar Health, Inc. Analysis →